Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.07 is 22% below its 5-year average of 6.50, near the low end of its 5-year range (0.61–32.34).
As of the fiscal period ended Tuesday, June 30, 2026. 65.71% above its 12-month average of 3.06.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.07.
QUICK RATIO (ACID-TEST)
5.07
QUICK RATIO (ACID-TEST) AVG TTM
3.06
QUICK RATIO (ACID-TEST) AVG 3Y
3.40
QUICK RATIO (ACID-TEST) AVG 5Y
6.50
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+65.71%
CURRENT VS 3Y AVG
+49.21%
CURRENT VS 5Y AVG
-22.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+51.32%
vs the sector median at left
PRF Technologies Ltd.
Market Cap
$71053.00
Quick Ratio (Acid-Test)
5.07
TTM Avg
3.06
3Y Avg
3.40
5Y Avg
6.50
Market Cap
$61172.00
Quick Ratio (Acid-Test)
0.22
TTM Avg
0.98
3Y Avg
0.56
5Y Avg
0.46
Market Cap
$95475.00
Quick Ratio (Acid-Test)
8.09
TTM Avg
12.83
3Y Avg
6.46
5Y Avg
13.37
Market Cap
$106970.00
Quick Ratio (Acid-Test)
0.94
TTM Avg
1.53
3Y Avg
2.70
5Y Avg
2.29
Market Cap
$30389.00
Quick Ratio (Acid-Test)
11.11
TTM Avg
11.47
3Y Avg
8.78
5Y Avg
8.76
Market Cap
$30054.00
Quick Ratio (Acid-Test)
4.15
TTM Avg
1.63
3Y Avg
2.55
5Y Avg
2.20
Market Cap
$6235.00
Quick Ratio (Acid-Test)
2.98
TTM Avg
2.06
3Y Avg
1.78
5Y Avg
1.50
Market Cap
$252756.00
Quick Ratio (Acid-Test)
2.38
TTM Avg
3.83
3Y Avg
3.05
5Y Avg
3.34
Market Cap
$378849.00
Quick Ratio (Acid-Test)
9.90
TTM Avg
8.52
3Y Avg
13.30
5Y Avg
8.87
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PRF Technologies Ltd. (PRFX) | $71053.00 | 5.07 | 3.06 | 3.40 | 6.50 |
| Akanda Corp. (AKAN)vs › | $61172.00 | 0.22 | 0.98 | 0.56 | 0.46 |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | 8.09 | 12.83 | 6.46 | 13.37 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $106970.00 | 0.94 | 1.53 | 2.70 | 2.29 |
| Zhongchao Inc. (ZCMD)vs › | $30389.00 | 11.11 | 11.47 | 8.78 | 8.76 |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30054.00 | 4.15 | 1.63 | 2.55 | 2.20 |
| NewGenIvf Group Limited (NIVF)vs › | $6235.00 | 2.98 | 2.06 | 1.78 | 1.50 |
| SciSparc Ltd. (SPRC)vs › | $252756.00 | 2.38 | 3.83 | 3.05 | 3.34 |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | 9.90 | 8.52 | 13.30 | 8.87 |
| Niki BioSolutions, Inc. (NIKI)vs › | $385197.00 | 0.78 | 0.50 | 0.69 | 2.39 |
Quick Ratio
5.07
Excludes inventory
Current Ratio
5.07
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.07 |
| 2026-03-31 | 5.07 |
| 2025-12-31 | 1.78 |
| 2025-09-30 | 1.78 |
| 2025-06-30 | 1.59 |
| 2025-03-31 | 1.59 |
| 2024-12-31 | 1.81 |
| 2024-09-30 | 1.81 |
| 2024-06-30 | 0.61 |
| 2024-03-31 | 1.61 |
| 2023-12-31 | 4.07 |
| 2023-09-30 | 9.81 |
| 2023-06-30 | 7.55 |
| 2023-03-31 | 8.10 |
| 2022-12-31 | 4.19 |
| 2022-09-30 | 12.40 |
| 2022-06-30 | 29.02 |
| 2022-03-31 | 22.99 |
| 2021-12-31 | 25.13 |
| 2021-09-30 | 32.34 |
| 2021-06-30 | 32.32 |
| 2021-03-31 | 28.79 |
| 2020-12-31 | 16.39 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.08 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.15 |
| 2019-09-30 | 0.15 |
| 2019-06-30 | 3.93 |
| 2019-03-31 | 3.93 |
| 2018-12-31 | 4.44 |
| 2018-09-30 | 4.44 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
